ARCHIVE

• How to Price of Innovative Drugs to Be Major Issue in FY2003: Mr Fujiyama of FPMAJ
  March 17, 2003

• CORPORATE ROUNDUP NEWS IN BRIEF
  March 17, 2003

• Industry FTC Outlines Stricter Measures to Prevent Code Violations
  March 17, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  March 17, 2003

• Fukujin Aims at Group Sales of \1 Trillion in 2006
  March 17, 2003

• OUA 3rd Academic Meeting Held
  March 17, 2003

• Toho Determined to Reach Price Accord by End of March
  March 17, 2003

• Deregulation WG Clashes with Korosho in OTC Sale
  March 17, 2003

• OPMA to Reorganize Its Structure
  March 17, 2003

• AJD to Expand Activities of Home Medication Kyokai
  March 17, 2003

• Drug-related Patent Applications Up Sharply in 2002: Patolis Survey
  March 17, 2003

• OTC NEWS IN BRIEF
  March 17, 2003

• BUSINESS NEWS IN BRIEF
  March 17, 2003

• ITX Aims for Sales of \8 bil. in Life Science Business by FY2006
  March 17, 2003

• NEW PRODUCTS
  March 17, 2003

• Shimadzu Acquires Non-exclusive License to Eiken's LAMP Method for Animal Disease
  March 17, 2003

• Donepezil, Rabeprazole Going on Strong Growth: Mr Naito of Eisai
  March 17, 2003

• 10 Contract Lab Test Centers Excluded from Nominative Tenders
  March 17, 2003

• Approval of Aventis Pharma's Arava, GSK's Imigran Recommended
  March 17, 2003

• DIAGNOSTIC NEWS IN BRIEF
  March 17, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 611
• 612
• 613
• 614
• 615
• 616
• 617
• 618
• 619
• …
• Next ›
• 最終 »